133 results on '"Mayadev J"'
Search Results
2. Durvalumab in Combination with Chemoradiotherapy (CRT) in Locally Advanced Cervical Cancer (LACC): Radiotherapy (RT) Delivery and Subgroup Analyses from CALLA
3. Erratum to “GCIG-Consensus guideline for long-term survivorship in gynecologic cancer: A position paper from the Gynecologic Cancer InterGroup (GCIG) symptom benefit committee” [Cancer Treatm. Rev. 107 (2022) 102396]
4. GCIG-Consensus guideline for Long-term survivorship in gynecologic Cancer: A position paper from the gynecologic cancer Intergroup (GCIG) symptom benefit committee
5. GCIG-Consensus guideline for Long-term survivorship in gynecologic Cancer: A position paper from the gynecologic cancer Intergroup (GCIG) symptom benefit committee
6. Erratum to 'GCIG-Consensus guideline for long-term survivorship in gynecologic cancer: A position paper from the Gynecologic Cancer InterGroup (GCIG) symptom benefit committee” [Cancer Treatm. Rev. 107 (2022) 102396] (Cancer Treatment Reviews (2022) 107, (S0305737222000603), (10.1016/j.ctrv.2022.102396))
7. The effect of weight loss on oncologic outcomes in patients receiving primary chemoradiation
8. Positron emission tomography as an imaging biomarker after chemoradiation and immunotherapy for cervical cancer patients treated on GOG 9929
9. Tumor Board and Clinical Hospice Discussions among Elderly, Advanced Stage Gynecology Oncology Patients
10. SU‐F‐T‐433: Evaluation of a New Dose Mimicking Application for Clinical Flexibility and Reliability
11. WE‐G‐BRC‐02: Risk Assessment for HDR Brachytherapy
12. Practice patterns for referral to radiation oncology for high risk post operative vulvar cancer
13. Excessive alcohol abuse decreases pelvic control and survival in locally advanced cervical cancer treated with chemoradiation
14. Prospective Evaluation of Patient Satisfaction Following the Use of Education Materials for Cervical Cancer Brachytherapy
15. SU‐E‐J‐160: Comparing the Setup Accuracy of Non‐Ionizing Patient Localization Systems with CBCT to Reduce Imaging Dose in Prone Breast Treatments
16. Optimizing the process for maximum safety and efficiency in tandem and ring brachytherapy for cervical cancer using the failure modes and effect analysis
17. Positive pelvic lymph nodes in locally advanced cervical cancer: How much dose is given by the high dose rate brachytherapy?
18. Lumbosacral Plexus Dose With High-Dose-Rate (HDR) Brachytherapy for Locally-Advanced Cervical Cancer
19. SU‐C‐137‐02: A Failure Mode and Effects Analysis for Tandem and Ring Brachytherapy
20. A Retrospective Analysis of Setup Reproducibility for Anorectal Cancer Patients Treated Prone on a Belly Board
21. Pelvic and Paraortic Lymph Node Response to Chemoradiation Therapy in Patients With Locally Advanced Cervical Cancer: Does a Higher Boost Dose Impact Nodal Control?
22. Radiographic response of pelvic and para-aortic lymphadenopathy to a radiation boost in the definitive management of locally advanced cervical cancer
23. A time and efficiency study of optimal implantation to treatment delivery in CT based image guided brachytherapy for locally advanced cervical cancer
24. PO-281 THE EFFECT OF BODY MASS INDEX ON MAXIMUM RECTAL DOSE IN HIGH DOSE RATE BRACHYTHERAPY FOR CERVICAL CANCER
25. Interfraction Motion of the Vaginal Apex in Patients With Gynecologic Malignancies Treated with Postoperative Intensity Modulated Radiation Therapy (IMRT): Are We Missing the Target?
26. SU‐E‐T‐254: Comprehensive Quality Assurance Program for Accelerated Partial Breast Irradiation Using the SAVI HDR Applicator
27. Practice patterns for referral to radiation oncology for high risk post operative vulvar cancer
28. Permanent Prostate Brachytherapy in Prostate Glands Less than 20 Cm3
29. Predictors of Response and Differential Mechanisms of Action for Anti-CD20 Radio-Immunotherapy
30. Positive pelvic lymph nodes in locally advanced cervical cancer: How much dose is given by the high dose rate brachytherapy?
31. Permanent prostate brachytherapy in prostate glands <LT>20 cm(3)
32. Practice patterns of MRI utilization for breast cancer treatment within the University of California system as part of the Athena initiative.
33. Positive pelvic lymph nodes in locally advanced cervical cancer: How much dose is given by the high dose rate brachytherapy?
34. Challenges and opportunities for early phase clinical trials of novel drug-radiotherapy combinations: recommendations from NRG Oncology, the American Society for Radiation Oncology (ASTRO), the American College of Radiology (ACR), the Sarah Cannon Research Institute, and the American College of Radiation Oncology (ACRO).
35. Neural network dose prediction for cervical brachytherapy: Overcoming data scarcity for applicator-specific models.
36. The Next Chapter in Immunotherapy and Radiation Combination Therapy: Cancer-Specific Perspectives.
37. Careful Reirradiation.
38. CALLA trial: immunotherapy in locally advanced cervical cancer - Authors' reply.
39. Design and Material Characterization of an Inflatable Vaginal Dilator.
40. Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial.
41. A practical guide to hybrid interstitial/intracavitary brachytherapy for locally-advanced cervical cancer.
42. A randomized patient education trial investigating treatment-related distress and satisfaction with the use of an at-home gynecologic brachytherapy educational video.
43. Forecasting patient-specific dosimetric benefit from daily online adaptive radiotherapy for cervical cancer.
44. Outcomes from a 3-fraction high-dose-rate brachytherapy regimen for patients with cervical cancer.
45. Automated treatment planning framework for brachytherapy of cervical cancer using 3D dose predictions.
46. Underutilization of brachytherapy for cervical cancer in the United States.
47. Dosimetric and feasibility evaluation of a CBCT-based daily adaptive radiotherapy protocol for locally advanced cervical cancer.
48. Retrospective review of three-fractioned accelerated partial breast irradiation.
49. Improved Prognosis of Treatment Failure in Cervical Cancer with Nontumor PET/CT Radiomics.
50. Knowledge-based three-dimensional dose prediction for tandem-and-ovoid brachytherapy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.